National Merchant Mariner Medical Advisory Committee; April 2021 Teleconference, 16378-16379 [2021-06426]
Download as PDF
16378
Federal Register / Vol. 86, No. 58 / Monday, March 29, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the
public as indicated below, the 93rd
meeting of the National Advisory
Council for Human Genome Research
open session will be livestreamed and
available for viewing to the public from
https://www.genome.gov/eventcalendar/93rd-Meeting-of-NationalAdvisory-Council-for-Human-GenomeResearch. The open session will be on
May 17th and the start time will be
11:30 a.m.
The portion of the meeting will also
be closed to the public in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: May 17–18, 2021.
Closed: May 17, 2021, 10:00 a.m. to 11:00
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892 (Virtual Meeting).
Open: May 17, 2021, 11:30 a.m. to 5:00
p.m.
Agenda: Report from Institute Director and
Program Staff.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892 (Virtual Meeting).
Closed: May 18, 2021, 10:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100,
Bethesda, MD 20892, (301) 402–0838,
pozzattr@mail.nih.gov.
Any interested person may file written
comments within 15 days after the meeting
VerDate Sep<11>2014
17:20 Mar 26, 2021
Jkt 253001
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: March 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michelle Marie Arnold,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1199, michelle.arnold@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2021–06373 Filed 3–26–21; 8:45 am]
Dated: March 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2021–06375 Filed 3–26–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Mycology, Parasitology
and Pathogenesis.
Date: April 23, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, 301–496–
6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Microbiota
and Mucosal Immunity.
Date: April 29, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke Amended; Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, April 01, 2021,
10:00 a.m. to April 02, 2021, 06:00 p.m.,
National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on February 26, 2021, 86 FR 11783.
This notice is being amended to make
this two-day meeting a three-day
meeting. The meeting will now be held
from March 31, 2021 to April 2, 2021.
The meeting time remains the same. The
meeting is closed to the public.
Dated: March 23, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–06367 Filed 3–26–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2021–0187]
National Merchant Mariner Medical
Advisory Committee; April 2021
Teleconference
U.S. Coast Guard, Department
of Homeland Security.
AGENCY:
E:\FR\FM\29MRN1.SGM
29MRN1
Federal Register / Vol. 86, No. 58 / Monday, March 29, 2021 / Notices
Notice of Federal Advisory
Committee teleconference meeting.
section of this
notice.
Docket Search: Documents mentioned
in this notice as being available in the
docket, and all public comments, will
be in our online docket at https://
www.regulations.gov and can be viewed
by following that website’s instructions.
Additionally, if you go to the online
docket and sign-up for email alerts, you
will be notified when comments are
posted.
FOR FURTHER INFORMATION CONTACT: Mr.
David Belliveau, Alternate Designated
Federal Officer of the National Merchant
Mariner Medical Advisory Committee,
telephone 202–372–1208 or email
david.j.belliveau@uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is in compliance with the
Federal Advisory Committee Act, 5
U.S.C. Appendix.
The National Merchant Mariner
Medical Advisory Committee Meeting is
authorized by § 601 of the Frank
LoBiondo Coast Guard Authorization
Act of 2018. The statutory authority is
codified in 46 U.S.C. 15104. The
Committee operates under the
provisions of the Federal Advisory
Committee Act (5 U.S.C. Appendix) in
addition to the provisions applicable to
all National Maritime Transportation
Advisory Committees in 46 U.S.C.
15109.
The Committee advises the Secretary
of the Department of Homeland Security
through the Commandant of the Coast
Guard on matters related to: (a) Medical
certification determinations for issuance
of licenses, certificates of registry, and
merchant mariners’ documents; (b)
medical standards and guidelines for
the physical qualifications of operators
of commercial vessels; (c) medical
examiner education; and (d) medical
research.
ACTION:
INFORMATION CONTACT
The National Merchant
Mariner Medical Advisory Committee
(Committee) will meet via
teleconference to discuss matters
relating to medical certification
determinations for issuance of licenses,
certificates of registry, and merchant
mariners’ documents, medical standards
and guidelines for the physical
qualifications of operators of
commercial vessels, medical examiner
education, and medical research. The
meeting will be open to the public.
DATES:
Meeting: The National Merchant
Mariner Medical Advisory Committee
will meet by teleconference on Monday,
April 19, 2021, from 11 a.m. until 3 p.m.
(EDT). The teleconference may adjourn
early if the Committee has completed its
business.
Comments and supporting
documentation: To ensure your
comments are received by Committee
members before the teleconference,
submit your written comments no later
than April 12, 2021.
ADDRESSES: To join the teleconference
or to request special accommodations,
contact the individual listed in the FOR
FURTHER INFORMATION CONTACT section
no later than 1 p.m. on April 12, 2021,
to obtain the needed information. The
number of teleconference lines are
limited and will be available on a firstcome, first-served basis.
Instructions: You are free to submit
comments at any time, including orally
at the teleconference as time permits,
but if you want Committee members to
review your comment before the
teleconference, please submit your
comments no later than April 12, 2021.
We are particularly interested in
comments on the issues in the
‘‘Agenda’’ section below. We encourage
you to submit comments through the
Federal eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, call or email the
individual in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions. You
must include the docket number
[USCG–2021–0187]. Comments received
will be posted without alteration at
https://www.regulations.gov, including
any personal information provided. For
more about privacy and submissions in
response to this document, see DHS’s
eRulemaking System of Records notice
(85 FR 14226, March 11, 2020). If you
encounter technical difficulties with
comment submission, contact the
individual listed in the FOR FURTHER
Agenda
The agenda for the April 19, 2021,
teleconference is as follows:
(1) Introduction.
(2) Designated Federal Officer
remarks.
(3) Introduction, roll call of
Committee members and determination
of a quorum.
(4) Remarks from U.S. Coast Guard
Leadership.
(5) Swearing in of Committee
Members.
(6) Election by committee members of
Chair and Vice Chair.
(7) Presentation of Tasks—The
Committee will review the tasks
presented by the Coast Guard and
determine if they will accept the tasks
to form Working Groups. The following
tasks will be considered for acceptance:
SUMMARY:
VerDate Sep<11>2014
17:20 Mar 26, 2021
Jkt 253001
PO 00000
Frm 00060
Fmt 4703
Sfmt 9990
16379
(a) Task Statement 21–X1,
Recommendations on Mariner Mental
Health (Formerly MEDMAC Task 18–
27);
(b) Task Statement 21–X2,
Communication Between External
Stakeholders and the Mariner
Credentialing Program (Formerly
MEDMAC Task 18–28);
(c) Task Statement 21–X3, Medical
Certifications for Military to Mariner
(Formerly MEDMAC Task 19–31);
(d) Task Statement 21–X4,
Recommendations on Appropriate Diets
and Wellness for Mariners While
Onboard Merchant Vessels (Formerly
MEDMAC Task 16–24); and
(e) Task Statement 21–X5, Review of
Proposed Revisions to the International
Convention on Standards of Training,
Certification and Watchkeeping for
Fishing Vessel Personnel (STCW–F)
Medical Standards.
(8) Introduction to Merchant Mariner
Medical Regulations and Policy.
(9) Introduction to the National
Maritime Center.
(10) Public comment period.
(11) Closing remarks/plans for next
meeting.
(12) Adjournment of meeting.
A copy of all meeting documentation
will be available at https://
homeport.uscg.mil/missions/federaladvisory-committees/nationalmerchant-mariner-medical-advisorycommittee-(nmedmac) no later than
April 12, 2021. Alternatively, you may
contact Mr. David Belliveau as noted in
the FOR FURTHER INFORMATION section
above.
During the April 19, 2021
teleconference, a public comment
period will be held immediately after
the introduction to the National
Maritime Center, at approximately 2:00
p.m. Public comments will be limited to
two minutes per speaker. Please note
that the public comments period will
end following the last call for
comments. Please contact the individual
listed in the FOR FURTHER INFORMATION
CONTACT section, to register as a speaker.
Dated: March 24, 2021.
Jeffrey G. Lantz,
Director of Commercial Regulations and
Standards.
[FR Doc. 2021–06426 Filed 3–26–21; 8:45 am]
BILLING CODE 9110–04–P
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 86, Number 58 (Monday, March 29, 2021)]
[Notices]
[Pages 16378-16379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06426]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Coast Guard
[Docket No. USCG-2021-0187]
National Merchant Mariner Medical Advisory Committee; April 2021
Teleconference
AGENCY: U.S. Coast Guard, Department of Homeland Security.
[[Page 16379]]
ACTION: Notice of Federal Advisory Committee teleconference meeting.
-----------------------------------------------------------------------
SUMMARY: The National Merchant Mariner Medical Advisory Committee
(Committee) will meet via teleconference to discuss matters relating to
medical certification determinations for issuance of licenses,
certificates of registry, and merchant mariners' documents, medical
standards and guidelines for the physical qualifications of operators
of commercial vessels, medical examiner education, and medical
research. The meeting will be open to the public.
DATES:
Meeting: The National Merchant Mariner Medical Advisory Committee
will meet by teleconference on Monday, April 19, 2021, from 11 a.m.
until 3 p.m. (EDT). The teleconference may adjourn early if the
Committee has completed its business.
Comments and supporting documentation: To ensure your comments are
received by Committee members before the teleconference, submit your
written comments no later than April 12, 2021.
ADDRESSES: To join the teleconference or to request special
accommodations, contact the individual listed in the FOR FURTHER
INFORMATION CONTACT section no later than 1 p.m. on April 12, 2021, to
obtain the needed information. The number of teleconference lines are
limited and will be available on a first-come, first-served basis.
Instructions: You are free to submit comments at any time,
including orally at the teleconference as time permits, but if you want
Committee members to review your comment before the teleconference,
please submit your comments no later than April 12, 2021. We are
particularly interested in comments on the issues in the ``Agenda''
section below. We encourage you to submit comments through the Federal
eRulemaking Portal at https://www.regulations.gov. If your material
cannot be submitted using https://www.regulations.gov, call or email
the individual in the FOR FURTHER INFORMATION CONTACT section of this
document for alternate instructions. You must include the docket number
[USCG-2021-0187]. Comments received will be posted without alteration
at https://www.regulations.gov, including any personal information
provided. For more about privacy and submissions in response to this
document, see DHS's eRulemaking System of Records notice (85 FR 14226,
March 11, 2020). If you encounter technical difficulties with comment
submission, contact the individual listed in the FOR FURTHER
INFORMATION CONTACT section of this notice.
Docket Search: Documents mentioned in this notice as being
available in the docket, and all public comments, will be in our online
docket at https://www.regulations.gov and can be viewed by following
that website's instructions. Additionally, if you go to the online
docket and sign-up for email alerts, you will be notified when comments
are posted.
FOR FURTHER INFORMATION CONTACT: Mr. David Belliveau, Alternate
Designated Federal Officer of the National Merchant Mariner Medical
Advisory Committee, telephone 202-372-1208 or email
[email protected].
SUPPLEMENTARY INFORMATION: Notice of this meeting is in compliance with
the Federal Advisory Committee Act, 5 U.S.C. Appendix.
The National Merchant Mariner Medical Advisory Committee Meeting is
authorized by Sec. 601 of the Frank LoBiondo Coast Guard Authorization
Act of 2018. The statutory authority is codified in 46 U.S.C. 15104.
The Committee operates under the provisions of the Federal Advisory
Committee Act (5 U.S.C. Appendix) in addition to the provisions
applicable to all National Maritime Transportation Advisory Committees
in 46 U.S.C. 15109.
The Committee advises the Secretary of the Department of Homeland
Security through the Commandant of the Coast Guard on matters related
to: (a) Medical certification determinations for issuance of licenses,
certificates of registry, and merchant mariners' documents; (b) medical
standards and guidelines for the physical qualifications of operators
of commercial vessels; (c) medical examiner education; and (d) medical
research.
Agenda
The agenda for the April 19, 2021, teleconference is as follows:
(1) Introduction.
(2) Designated Federal Officer remarks.
(3) Introduction, roll call of Committee members and determination
of a quorum.
(4) Remarks from U.S. Coast Guard Leadership.
(5) Swearing in of Committee Members.
(6) Election by committee members of Chair and Vice Chair.
(7) Presentation of Tasks--The Committee will review the tasks
presented by the Coast Guard and determine if they will accept the
tasks to form Working Groups. The following tasks will be considered
for acceptance:
(a) Task Statement 21-X1, Recommendations on Mariner Mental Health
(Formerly MEDMAC Task 18-27);
(b) Task Statement 21-X2, Communication Between External
Stakeholders and the Mariner Credentialing Program (Formerly MEDMAC
Task 18-28);
(c) Task Statement 21-X3, Medical Certifications for Military to
Mariner (Formerly MEDMAC Task 19-31);
(d) Task Statement 21-X4, Recommendations on Appropriate Diets and
Wellness for Mariners While Onboard Merchant Vessels (Formerly MEDMAC
Task 16-24); and
(e) Task Statement 21-X5, Review of Proposed Revisions to the
International Convention on Standards of Training, Certification and
Watchkeeping for Fishing Vessel Personnel (STCW-F) Medical Standards.
(8) Introduction to Merchant Mariner Medical Regulations and
Policy.
(9) Introduction to the National Maritime Center.
(10) Public comment period.
(11) Closing remarks/plans for next meeting.
(12) Adjournment of meeting.
A copy of all meeting documentation will be available at https://homeport.uscg.mil/missions/federal-advisory-committees/national-merchant-mariner-medical-advisory-committee-(nmedmac) no later than
April 12, 2021. Alternatively, you may contact Mr. David Belliveau as
noted in the FOR FURTHER INFORMATION section above.
During the April 19, 2021 teleconference, a public comment period
will be held immediately after the introduction to the National
Maritime Center, at approximately 2:00 p.m. Public comments will be
limited to two minutes per speaker. Please note that the public
comments period will end following the last call for comments. Please
contact the individual listed in the FOR FURTHER INFORMATION CONTACT
section, to register as a speaker.
Dated: March 24, 2021.
Jeffrey G. Lantz,
Director of Commercial Regulations and Standards.
[FR Doc. 2021-06426 Filed 3-26-21; 8:45 am]
BILLING CODE 9110-04-P